<?xml version="1.0" encoding="UTF-8"?>
<p id="p0045">High variability is reported in the timing of skin manifestations, with some studies identifying skin findings days before respiratory signs and others weeks after recovery. Researchers speculate that COVID-19 skin findings are caused by an inflammatory response to the infection that results in complement-mediated microvascular injury (
 <xref rid="b0270" ref-type="bibr">Magro et al., 2020</xref>). Some reports discuss the difficulty in confirming that cutaneous manifestations are specific to SARS-CoV-2; many critically ill patients receive multiple medication regimens that can yield similar cutaneous findings (
 <xref rid="b0450" ref-type="bibr">Young and Fernandez, 2020</xref>). Although there is no necessary treatment for COVID-related cutaneous manifestations, dermatologists should follow American Academy of Dermatology guidance when prescribing immunosuppressive agents for autoimmune-mediated conditions normally treated with biologics (
 <xref rid="b0005" ref-type="bibr">American Academy of Dermatology, 2020</xref>).
</p>
